Pfizer Aktie
WKN: 852009 / ISIN: US7170811035
05.04.2011 14:00:00
|
SpringSoft, Real Intent Host Seminar on Advances in System-On-Chip Functional Verification Sign-off
SpringSoft, Inc. (TAIEX: 2473) and Real Intent, Inc. will host a free technical seminar in Silicon Valley on the latest electronic design automation (EDA) developments targeted at accelerating verification sign-off of complex integrated circuit (IC) and system-on-chip (SoC) designs. The agenda features a keynote address by Anant Agrawal, President and CEO of Verayo, Inc., and a founding member of the SPARC processor team at Sun Microsystems.
Technology experts from SpringSoft and Real Intent will present technical sessions on hot topics such as clock domain crossing (CDC) sign-off, verification closure, X-propagation verification, and efficient SystemVerilog testbench development. User case study presentations by YC Wong of Broadcom and Himanshu Bhatnagar of Mindspeed will discuss the verification challenges, tools and methodologies of advanced sign-off flows.
Lunch will be served before the keynote presentation, and two iPads will be given away in a drawing at the conclusion of the seminar. Registration is now open.
When: |
Thursday, May 5, 2011, 12:00 – 5:00 p.m. |
||
Where: |
TechMart |
||
|
5201 Great America Parkway |
||
|
Santa Clara, CA 95054 |
Agenda: |
Keynote Address and Luncheon | ||
Technical Sessions:
|
|||
Case Studies:
|
|||
Conclusion and Prize Drawing |
Registration: |
For more information or to register online, visit: http://www.springsoft.com/ri-ss-seminar |
About SpringSoft
SpringSoft, Inc. is a global supplier of specialized automation technologies that accelerate engineers during the design, verification and debug of complex digital, analog and mixed-signal ICs, ASICs, microprocessors, and SoCs. Its award-winning product portfolio features the Novas™ Verification Enhancement and Laker™ Custom IC Design solutions used by more than 400 of today's leading IDM and fabless semiconductor companies, foundries, and electronic systems OEMs. Headquartered in Hsinchu, Taiwan, SpringSoft is the largest company in Asia specializing in IC design software and a recognized industry leader in customer service with more than 400 employees located in multiple R&D sites and local support offices around the world. For more information, visit www.springsoft.com.
About Real Intent
Real Intent is the leader in automating the intelligence of formal techniques for Advanced Sign-off of electronic designs. Its software dramatically improves functional verification efficiency and design quality for System-on-Chip devices and is used by design and verification teams worldwide. For more information, please visit www.realintent.com.
Novas and Laker are trademarks of SpringSoft, Inc. All other trademarks or registered trademarks are the property of their respective owners.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6672223&lang=en

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Pfizer Inc.mehr Nachrichten
14.05.25 |
ROUNDUP/SMS an Pfizer: Von der Leyen kassiert Schlappe vor Gericht (dpa-AFX) | |
14.05.25 |
EU court rules against Ursula von der Leyen over missing Pfizer texts (Financial Times) | |
14.05.25 |
POLITIK: Schlappe für von der Leyen im Prozess um SMS an Pfizer-Chef (dpa-AFX) | |
13.05.25 |
S&P 500-Papier Pfizer-Aktie: So viel Verlust hätte eine Pfizer-Investition von vor einem Jahr eingebracht (finanzen.at) | |
06.05.25 |
S&P 500-Titel Pfizer-Aktie: So viel Verlust hätte eine Pfizer-Investition von vor 10 Jahren eingebracht (finanzen.at) | |
29.04.25 |
S&P 500-Titel Pfizer-Aktie: So viel Verlust hätte eine Pfizer-Investition von vor 5 Jahren eingebracht (finanzen.at) | |
29.04.25 |
Ausblick: Pfizer legt Quartalsergebnis vor (finanzen.net) | |
25.04.25 |
S&P 500-Wert Pfizer-Aktie: Über diese Dividendenzahlung können sich Pfizer-Aktionäre freuen (finanzen.at) |
Analysen zu Pfizer Inc.mehr Analysen
29.04.25 | Pfizer Buy | Jefferies & Company Inc. | |
29.04.25 | Pfizer Neutral | JP Morgan Chase & Co. | |
29.04.25 | Pfizer Neutral | UBS AG | |
14.04.25 | Pfizer Buy | Jefferies & Company Inc. | |
14.04.25 | Pfizer Neutral | UBS AG |
Aktien in diesem Artikel
Pfizer Inc. | 20,40 | 1,19% |
|
Indizes in diesem Artikel
Dow Jones | 42 654,74 | 0,78% | |
S&P 500 | 5 958,38 | 0,70% | |
S&P 100 | 2 893,14 | 0,59% | |
NYSE US 100 | 16 786,20 | 1,04% |